Acadia Healthcare (NASDAQ:ACHC) Updates FY 2025 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 2.500-2.800 for the period, compared to the consensus estimate of 3.360. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.4 billion. Acadia Healthcare also updated its Q1 2025 guidance to EPS.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $29.98 on Friday. The stock has a market capitalization of $2.78 billion, a P/E ratio of 9.83, a P/E/G ratio of 1.46 and a beta of 1.30. The company’s 50-day moving average is $42.10 and its 200 day moving average is $51.93. Acadia Healthcare has a 1 year low of $29.79 and a 1 year high of $86.56. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Analyst Ratings Changes

A number of equities analysts have commented on ACHC shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Bank of America reduced their price objective on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday. Barclays lowered Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $43.00 to $35.00 in a research note on Friday. TD Cowen lowered their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Finally, StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and an average price target of $59.56.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.